Verret D J, Leach J L, Gilmore J
Department of Otolaryngology-Head and Neck Surgery, University of Texas Southwestern Medical School at Dallas, USA.
Arch Facial Plast Surg. 2006 Nov-Dec;8(6):423-5. doi: 10.1001/archfaci.8.6.423.
To evaluate the clinical outcomes with the use of a dual-porosity expanded polytetrafluoroethylene implant for midfacial rejuvenation.
An institutional review board-approved retrospective chart review was conducted of all patients who underwent implantation with the dual-porosity expanded polytetrafluoroethylene implant between 2001 and 2005.
A total of 170 patients, with 612 implants, were evaluated. Only 8 patients had minor complications, 3 of which necessitated implant removal. The overall results of independent observer analysis of outcomes were favorable in the majority of cases.
The dual-porosity expanded polytetrafluoroethylene implant is safe and reliable to use for midfacial implantation.